GEN1 and Dysmenorrhea: All this evidence indicates that RES and GEN probably do not affect endogenous prostaglandin synthesis but can modulate uterus contractility by suppressing PGF2α-induced uterine contractions; therefore, RES and GEN may have the potential for use in the treatment or improvement of dysmenorrhea.